US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Lantheus Holdings, Inc. - Common Stock
(NQ:
LNTH
)
99.70
-0.29 (-0.29%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lantheus Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
1 Russell 2000 Stock with Exciting Potential and 2 That Underwhelm
October 12, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via
StockStory
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
October 06, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via
StockStory
Topics
Economy
3 Reasons LNTH is Risky and 1 Stock to Buy Instead
September 23, 2026
Lantheus currently trades at $100.02 and has been a dream stock for shareholders. It’s returned 270% since September 2021, blowing past the S&P 500’s 74.5% g...
Via
StockStory
Topics
Stocks
2 Small-Cap Stocks to Consider Right Now and 1 That Underwhelm
September 11, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Lantheus Holdings (NASDAQ:LNTH) Is a High-Quality Technical Breakout Setup
↗
July 20, 2026
Via
Chartmill
Lantheus (NASDAQ:LNTH) Beats Q1 Estimates, Guides In Line, And Wall Street Is Paying Attention
↗
May 07, 2026
Via
Chartmill
Lantheus Holdings (NASDAQ:LNTH): A Decent Value Pick in Diagnostic Imaging
↗
April 23, 2026
Via
Chartmill
Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH)
August 19, 2026
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare equipment and supplies indu...
Via
StockStory
Topics
Economy
Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026
August 06, 2026
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.7% year on yea...
Via
StockStory
Earnings To Watch: Lantheus (LNTH) Reports Q2 Results Tomorrow
August 04, 2026
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting results this Thursday before the bell. Here’s what investors should know. Lanth...
Via
StockStory
1 Healthcare Stock Worth Your Attention and 2 We Question
July 30, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...
Via
StockStory
1 Unpopular Stock That Deserves a Second Chance and 2 We Ignore
July 17, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via
StockStory
3 Reasons to Avoid LNTH and 1 Stock to Buy Instead
July 14, 2026
What a fantastic six months it’s been for Lantheus. Shares of the company have skyrocketed 60.5%, hitting $105.30. This was partly thanks to its solid quarte...
Via
StockStory
1 Small-Cap Stock with Competitive Advantages and 2 We Brush Off
July 13, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Healthcare Equipment and Supplies Stocks Q1 Teardown: Lantheus (NASDAQ:LNTH) Vs The Rest
June 23, 2026
Looking back on healthcare equipment and supplies stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Lantheus (NASDAQ:LNTH) ...
Via
StockStory
Topics
Economy
3 Healthcare Stocks with Open Questions
June 12, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via
StockStory
1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges
June 08, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Via
StockStory
Why This Fund Cashed Out of a Stock That Soared 250% in Just One Year
↗
May 31, 2026
This energy services provider delivers drilling, technology, and equipment solutions to oil and gas clients across more than 20 countries.
Via
The Motley Fool
Topics
Regulatory Compliance
3 Hyped Up Stocks with Warning Signs
May 14, 2026
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...
Via
StockStory
Lantheus (LNTH) Q1 2026 Earnings Transcript
↗
May 08, 2026
Lantheus (LNTH) Q1 2026 Earnings Transcript
Via
The Motley Fool
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results
↗
May 08, 2026
Lantheus Holdings Inc (NASDAQ:LNTH) reported upbeat Q1 earnings, reaffirmed guidance, and received price target hikes from analysts.
Via
Benzinga
Lantheus Q1 Earnings Call Highlights
↗
May 08, 2026
Lantheus (NASDAQ:LNTH) reported what management described as a strong start to 2026, citing solid performance from its three core commercial products—PYLARIFY, Neuraceq® and DEFINITY—and progress on...
Via
MarketBeat
Topics
Earnings
Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 Sales
May 07, 2026
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.2% year on ...
Via
StockStory
Lantheus (LNTH) Q1 Earnings Report Preview: What To Look For
May 05, 2026
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting results this Thursday before the bell. Here’s what to look for. Lantheus beat a...
Via
StockStory
1 Healthcare Stock to Target This Week and 2 We Ignore
April 22, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Via
StockStory
3 Profitable Stocks We Think Twice About
April 09, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
3 Cash-Producing Stocks Walking a Fine Line
April 08, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
April 07, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
3 Russell 2000 Stocks We’re Skeptical Of
March 25, 2026
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...
Via
StockStory
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application
↗
March 17, 2026
The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29.
Via
Stocktwits
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
